Axiom Advisory »

Alnylam Pharmaceuticals shares owned by Axiom Advisory

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Axiom Advisory from 13F filings

Historical chart of Axiom Advisory investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Axiom Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Axiom Advisory

Quarter filed Position value Share count Share price at filing
2024-09-30 $283k 1.1k 260.36

More positions owned by Axiom Advisory

Vanguard Index Fds Growth Etf (VUG)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Eafe Grwth Etf (EFG)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Vanguard Intl Equity Index F Ftse Smcap Etf (VSS)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Vanguard Index Fds Real Estate Etf (VNQ)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
NVIDIA Corporation (NVDA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares U S Etf Tr Gsci Cmdty Stgy (COMT)

View all positions for Axiom Advisory

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
FMR
Vanguard Group
BlackRock
Capital Research Global Investors
Regeneron Pharmaceuticals
Wellington Management Company
Baillie Gifford & Co
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Norges Bank Investment Management
Jpmorgan Chase & Co
Geode Capital Management

View all funds holding Alnylam Pharmaceuticals